SGHT vs. ARMP

Last updated Apr 1, 2026

Compare and contrast key facts about Sight Sciences, Inc. (SGHT) and Armata Pharmaceuticals Inc. (ARMP).

Performance

SGHT vs. ARMP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sight Sciences, Inc. (SGHT) and Armata Pharmaceuticals Inc. (ARMP). The values are adjusted to include any dividend payments, if applicable.

SGHT vs. ARMP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
SGHT Sight Sciences, Inc.	-52.46%	117.86%	-29.46%	-57.74%	-30.51%	-47.55%
ARMP Armata Pharmaceuticals Inc.	63.06%	239.46%	-42.90%	161.29%	-77.37%	44.21%

Fundamentals

Market Cap SGHT : $200.12M ARMP : $371.09M
EPS SGHT : -$0.73 ARMP : -$4.80
PS Ratio SGHT : 2.55 ARMP : 57.24
Total Revenue (TTM) SGHT : $77.36M ARMP : $6.48M
Gross Profit (TTM) SGHT : $66.67M ARMP : $5.00M
EBITDA (TTM) SGHT : -$33.70M ARMP : -$58.74M

Returns By Period

In the year-to-date period, SGHT achieves a -52.46% return, which is significantly lower than ARMP's 63.06% return.

SGHT

• 1D: 2.45%
• 1M: -26.94%
• YTD: -52.46%
• 6M: 9.59%
• 1Y: 57.08%
• 3Y*: -24.44%
• 5Y*: —
• 10Y*: —

ARMP

• 1D: 19.21%
• 1M: -4.83%
• YTD: 63.06%
• 6M: 243.62%
• 1Y: 601.37%
• 3Y*: 83.03%
• 5Y*: 16.66%
• 10Y*: -32.31%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SGHT vs. ARMP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SGHT

SGHT Risk / Return Rank: 64
SGHT Sharpe Ratio Rank: 66
SGHT Sortino Ratio Rank: 69
SGHT Omega Ratio Rank: 67
SGHT Calmar Ratio Rank: 59
SGHT Martin Ratio Rank: 61

ARMP

ARMP Risk / Return Rank: 98
ARMP Sharpe Ratio Rank: 98
ARMP Sortino Ratio Rank: 98
ARMP Omega Ratio Rank: 97
ARMP Calmar Ratio Rank: 99
ARMP Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SGHT vs. ARMP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sight Sciences, Inc. (SGHT) and Armata Pharmaceuticals Inc. (ARMP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SGHT	ARMP	Difference
Sharpe ratio Return per unit of total volatility	0.70	3.79	-3.09
Sortino ratio Return per unit of downside risk	1.56	4.73	-3.16
Omega ratio Gain probability vs. loss probability	1.20	1.60	-0.40
Calmar ratio Return relative to maximum drawdown	0.78	14.39	-13.62
Martin ratio Return relative to average drawdown	2.06	38.08	-36.02
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SGHT vs. ARMP - Sharpe Ratio Comparison

The current SGHT Sharpe Ratio is 0.70, which is lower than the ARMP Sharpe Ratio of 3.79. The chart below compares the historical Sharpe Ratios of SGHT and ARMP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SGHT	ARMP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.70	3.79	-3.09
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.15	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.29	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.41	-0.23	-0.18

Correlation

The correlation between SGHT and ARMP is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SGHT vs. ARMP - Dividend Comparison

Neither SGHT nor ARMP has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

SGHT vs. ARMP - Drawdown Comparison

The maximum SGHT drawdown since its inception was -96.70%, roughly equal to the maximum ARMP drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for SGHT and ARMP.

Drawdown Indicators

	SGHT	ARMP	Difference
Max Drawdown Largest peak-to-trough decline	-96.70%	-99.98%	+3.28%
Max Drawdown (1Y) Largest decline over 1 year	-61.66%	-37.22%	-24.44%
Max Drawdown (5Y) Largest decline over 5 years	—	-85.70%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.84%	—
Current Drawdown Current decline from peak	-90.36%	-99.79%	+9.43%
Average Drawdown Average peak-to-trough decline	-77.43%	-82.58%	+5.15%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.26%	14.40%	+8.86%

Volatility

SGHT vs. ARMP - Volatility Comparison

Sight Sciences, Inc. (SGHT) has a higher volatility of 37.65% compared to Armata Pharmaceuticals Inc. (ARMP) at 32.05%. This indicates that SGHT's price experiences larger fluctuations and is considered to be riskier than ARMP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SGHT	ARMP	Difference
Volatility (1M) Calculated over the trailing 1-month period	37.65%	32.05%	+5.60%
Volatility (6M) Calculated over the trailing 6-month period	64.69%	104.47%	-39.78%
Volatility (1Y) Calculated over the trailing 1-year period	82.63%	160.36%	-77.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	91.79%	112.19%	-20.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	91.79%	112.45%	-20.66%

Financials